Amalgamated Bank’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-26,662
Closed -$2.14M 1543
2016
Q4
$2.14M Buy
26,662
+5,274
+25% +$419K 0.1% 190
2016
Q3
$1.71M Buy
21,388
+72
+0.3% +$5.81K 0.1% 189
2016
Q2
$1.78M Buy
21,316
+10,619
+99% +$757K 0.1% 180
2016
Q1
$588K Buy
10,697
+2,666
+33% +$145K 0.06% 445
2015
Q4
$496K Sell
8,031
-2,263
-22% -$143K 0.06% 448
2015
Q3
$649K Buy
10,294
+355
+4% +$25.3K 0.07% 361
2015
Q2
$726K Buy
9,939
+343
+4% +$24.8K 0.07% 332
2015
Q1
$628K Buy
9,596
+2,277
+31% +$151K 0.08% 334
2014
Q4
$476K Sell
7,319
-1,109
-13% -$71.4K 0.07% 357
2014
Q3
$507K Buy
8,428
+365
+5% +$23.8K 0.08% 340
2014
Q2
$558K Buy
8,063
+952
+13% +$61.7K 0.08% 295
2014
Q1
$465K Sell
7,111
-154
-2% -$10K 0.08% 352
2013
Q4
$450K Buy
+7,265
New +$421K 0.08% 360

Other funds holding STJ

Amalgamated Bank's STJ Position: Q1 2017 in Review

Amalgamated Bank sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 26,662 shares — an estimated $2.14M sold.

Amalgamated Bank first reported a position in STJ in Q4 2013 and held it in 13 quarters. The position peaked at $2.14M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Amalgamated Bank reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Amalgamated Bank sold 26,662 St Jude Medical shares in Q1 2017, an estimated $2.14M.
  • Amalgamated Bank first reported a position in St Jude Medical in Q4 2013 and held it in 13 quarters.
  • Amalgamated Bank's St Jude Medical position peaked at $2.14M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Amalgamated Bank's 13F filing for Q1 2017, filed 12 May 2017.